BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 20028656)

  • 1. The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway.
    Xu H; Su Z; Wu J; Yang M; Penninger JM; Martin CM; Kvietys PR; Rui T
    J Immunol; 2010 Feb; 184(3):1492-8. PubMed ID: 20028656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of phospholipase Cgamma1 signalling attenuates cardiac tumor necrosis factor-alpha expression and improves myocardial function during endotoxemia.
    Peng T; Shen E; Fan J; Zhang Y; Arnold JM; Feng Q
    Cardiovasc Res; 2008 Apr; 78(1):90-7. PubMed ID: 18079103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia.
    Tavener SA; Long EM; Robbins SM; McRae KM; Van Remmen H; Kubes P
    Circ Res; 2004 Oct; 95(7):700-7. PubMed ID: 15358664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway.
    Yao Y; Xu X; Zhang G; Zhang Y; Qian W; Rui T
    Basic Res Cardiol; 2012 May; 107(3):267. PubMed ID: 22527657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of neuronal nitric oxide synthase in lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal mouse cardiomyocytes.
    Geoghegan-Morphet N; Burger D; Lu X; Sathish V; Peng T; Sims SM; Feng Q
    Cardiovasc Res; 2007 Jul; 75(2):408-16. PubMed ID: 17466955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipase Cgamma1 signalling regulates lipopolysaccharide-induced cyclooxygenase-2 expression in cardiomyocytes.
    Shen E; Fan J; Chen R; Yee SP; Peng T
    J Mol Cell Cardiol; 2007 Sep; 43(3):308-18. PubMed ID: 17655858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
    Tang Y; Lv B; Wang H; Xiao X; Zuo X
    Int Immunopharmacol; 2008 Dec; 8(12):1646-51. PubMed ID: 18713653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia.
    Fallach R; Shainberg A; Avlas O; Fainblut M; Chepurko Y; Porat E; Hochhauser E
    J Mol Cell Cardiol; 2010 Jun; 48(6):1236-44. PubMed ID: 20211628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for cardiomyocyte toll-like receptor 4 in endotoxemia?
    Tavener SA; Kubes P
    Trends Cardiovasc Med; 2005 Jul; 15(5):153-7. PubMed ID: 16165010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular or pharmacologic inhibition of the CD14 signaling pathway protects against burn-related myocardial inflammation and dysfunction.
    Barber RC; Maass DL; White DJ; Chang LY; Horton JW
    Shock; 2008 Dec; 30(6):705-13. PubMed ID: 18461018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.
    Oudit GY; Crackower MA; Eriksson U; Sarao R; Kozieradzki I; Sasaki T; Irie-Sasaki J; Gidrewicz D; Rybin VO; Wada T; Steinberg SF; Backx PH; Penninger JM
    Circulation; 2003 Oct; 108(17):2147-52. PubMed ID: 12963636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
    Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivotal advances: high-mobility group box 1 protein--a cytokine with a role in cardiac repair.
    Germani A; Limana F; Capogrossi MC
    J Leukoc Biol; 2007 Jan; 81(1):41-5. PubMed ID: 16940333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility.
    Avlas O; Fallach R; Shainberg A; Porat E; Hochhauser E
    Antioxid Redox Signal; 2011 Oct; 15(7):1895-909. PubMed ID: 21126202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-alpha expression and myocardial depression.
    Peng T; Lu X; Feng Q
    Circulation; 2005 Apr; 111(13):1637-44. PubMed ID: 15795323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group [corrected] box 1 mediates neutrophil recruitment in myocardial ischemia-reperfusion injury through toll like receptor 4-related pathway.
    Ding HS; Yang J; Gong FL; Yang J; Ding JW; Li S; Jiang YR
    Gene; 2012 Nov; 509(1):149-53. PubMed ID: 22890140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning.
    Ban K; Cooper AJ; Samuel S; Bhatti A; Patel M; Izumo S; Penninger JM; Backx PH; Oudit GY; Tsushima RG
    Circ Res; 2008 Sep; 103(6):643-53. PubMed ID: 18688045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of PI3Kγ/Akt pathway increases cardiomyocyte HMGB1 expression in diabetic environment.
    Song J; Liu Q; Tang H; Tao A; Wang H; Kao R; Rui T
    Oncotarget; 2016 Dec; 7(49):80803-80810. PubMed ID: 27821807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism.
    Oh YJ; Youn JH; Ji Y; Lee SE; Lim KJ; Choi JE; Shin JS
    J Immunol; 2009 May; 182(9):5800-9. PubMed ID: 19380828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.